Skip to main content
OpenTrials

Clinical trial condition

Proteostasis Deficiencies

Explore clinical trials studying Proteostasis Deficiencies. Study availability and eligibility vary by location and protocol.

1,350 public trials 353 recruiting studies
Refine in advanced search Browse all conditions

Proteostasis Deficiencies trial results

Active, Not Recruiting

A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

NCT06441682

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • UZ Leuven Leuven, Belgium
  • Kaye Edmonton Clinic Edmonton, Canada
  • Montreal Neurological Institute and Hospital Montreal, Canada
  • Aarhus Universitets Hospital Aarhus, Denmark
View Trial Details
Active, Not Recruiting

ALS Diagnosis From a Saliva Sample: a Non-coding RNA Analysis Approach

NCT05928416

Conditions
Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis, Sporadic, Amyotrophic lateral sclerosis 1, +10 more
Locations
  • CHU Strasbourg Strasbourg, Alsace, France
  • CHU Nantes Saint-Herblain, Loire-Atlantique, France
  • C.H.U. de Saint-Étienne Saint-Étienne-de-Montluc, Pays de la Loire Region, France
  • Hospices Civils de Lyon Bron, Rhône, France
View all 19 locations
View Trial Details
Active, Not Recruiting

Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS

NCT04057898

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • University of California Orange, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Augusta University Augusta, Georgia, United States
  • Indiana University IU Health Neuroscience Center Indianapolis, Indiana, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Study of ALXN2220 Versus Placebo in Adults With ATTR-CM

NCT06183931

Conditions
Amyloidosis, Metabolic Diseases, Nutritional and Metabolic Diseases, +2 more
Locations
  • Research Site Irvine, California, United States
  • Research Site La Jolla, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 212 locations
View Trial Details

Related conditions